Organogenesis Holdings Inc. Class A Common Stock (ORGO) Stock Price

ORGOStock
$1.7465.85%52W
Market Cap$223.89M
P/E6.24x
PEG Ratio6.54
Div yield
Beta1.28

ORGO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-67.76%
Price vs S&P 500 (4W)-37.04%
PEG Ratio6.54
VGM Score52.65
P/E Ratio (Annual)6.24x

ORGO Earnings Surprise History

Q2 25-0.06est. -0.01
Q3 250.18est. 0.07
Q4 250.40est. 0.21
Q1 26-0.34est. -0.29
Q2 26-0.69est. -0.35

ORGO Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.29
2.29
2.29
2.29

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ORGOOrganogenesis Holdings Inc. Class A Common Stock
BBF$1.74
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Organogenesis Holdings Inc. Class A Common Stock

Organogenesis is a regenerative medicine company specializing in advanced wound care, surgical, and sports medicine markets. The company develops and commercializes bioengineered tissue products designed to accelerate healing and improve surgical outcomes. Its portfolio includes solutions for chronic wound management, acute surgical applications, and soft tissue repair across hospital and outpatient settings.